N C Lee Selected Research

Cyclophosphamide (Cytoxan)

12/2001

Pre-existing tumor-sensitized T cells are essential for eradication of established tumors by IL-12 and cyclophosphamide plus IL-12.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N C Lee Research Topics

Disease

5	Neoplasms (Cancer) 12/2001 - 01/2000
1	Diabetes Mellitus 12/2014
1	Deglutition Disorders (Dysphagia) 01/2013
1	Disease Progression 01/2013
1	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2013
1	Methylmalonic acidemia 05/2010
1	Breast Neoplasms (Breast Cancer) 09/2001
1	Pheochromocytoma 11/2000
1	Ovarian Epithelial Carcinoma 04/2000
1	Neoplasm Metastasis (Metastasis) 01/2000
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2000

Drug/Important Bio-Agent (IBA)

1	Glucose (Dextrose)FDA LinkGeneric 12/2014
1	miglustat (Zavesca)FDA Link 01/2013
1	Methylmalonic AcidIBA 05/2010
1	Interleukin-12 (IL 12)IBA 12/2001
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2001
1	Hormones (Hormone)IBA 01/2001
1	SteroidsIBA 01/2001
1	CatecholaminesIBA 11/2000
1	Green Fluorescent ProteinsIBA 01/2000
1	Gemcitabine FDA Link 01/2000

Therapy/Procedure

2	Therapeutics 01/2013 - 12/2001
1	Liver Transplantation 05/2010
1	Immunotherapy 12/2001
1	Segmental Mastectomy (Lumpectomy) 09/2001
1	Mastectomy (Mammectomy) 09/2001
1	Radiotherapy 09/2001
1	Hysterectomy 08/2001
1	Thyroidectomy 11/2000
1	Adrenalectomy 11/2000
1	Estrogen Replacement Therapy 04/2000